Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Second case of Brucella canis in the UK
'The case highlights again the need for veterinary professionals to be alert to the possibility of potentially zoonotic B canis in dogs.'
Affected dog was imported from Bosnia

The Animal and Plant Health Agency (APHA) has confirmed a second UK case of Brucella canis in a dog imported from Eastern Europe.

A male dog, aged around five months, was imported from Bosnia in November 2015 and presented with reluctance to move, stilted hindlimb gait and intermittent lameness in October last year.

After two positive results on serological testing for B canis in March 2017, the APHA confirmed B canis by phenotypic and molecular approaches. Writing in Vet Record letters, the APHA said the dog is undergoing an eight-week course of doxycycline, with a good response so far.

This case is the second to be confirmed in the UK this year. A rescue dog imported from Romania and adopted in January 2016 was later presented to a veterinary practice in Leicestershire. It was showing intermittent signs of pain when rising from a sitting position and lesions consistent with diskospondylitis were detected via radiography.

Signs resolved after antibiotic treatment but recurred after treatment stopped, with a gradual deterioration of the dog’s overall health. Earlier this year, testing at APHA Weybridge confirmed B canis.

The organism was not previously thought to be present in the UK.

APHA wrote in Vet Record: ‘The case highlights again the need for veterinary professionals to be alert to the possibility of potentially zoonotic B canis in dogs, and particularly in imported animals, with reproductive or chronic inflammatory disease.’

Become a member or log in to add this story to your CPD history

Annual submission deadline small pet animal exemptions

News Story 1
 Companies marketing medicines for small pets exempt from authorisation must submit their annual return to the Veterinary Medicines Directorate (VMD) by 30 November 2026.

Submitting this annual return ensures continued compliance with regulatory requirements for products marketed without a full Marketing Authorisation. The exemption specifically applies to products intended for animals, cage birds, terrarium animals, small rodents, ferrets and rabbits.

For further details and submission guidelines, visit the gov.uk website.  

Click here for more...
News Shorts
BVA urges 'continued vigilance' over bluetongue

The British Veterinary Association (BVA) has urged vigilance following a concerning rise in Bluetongue (BTV) cases in sheep and cattle.

In a recent statement, the BVA noted that members are reporting more severe clinical signs and higher mortality rates than in previous years.

'We know that farm vets are working hard to support farmers and animals affected by this outbreak, during what is an extremely difficult time for all involved,' they stated. 'Continued vigilance to identify disease early is vital and vaccination remains the best way of protecting animals from this disease.'